| |
| |
|
| Insider
Information: |
Azamian Bobak R. |
| Relationship: |
President/CEO and Boar... |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
26,456 |
|
|
Indirect Shares
|
830,106 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
856,562 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tarsus Pharmaceuticals, Inc. |
TARS |
President/CEO and Boar... |
2024-03-18 |
26,456 |
2024-03-18 |
830,106 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEOOfficer |
• • • |
2020-10-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,211,696 |
|
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-08-10 |
4 |
AS |
$25.00 |
$2,575 |
I/I |
(103) |
1,229,355 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-01-20 |
4 |
AS |
$15.00 |
$3,600 |
I/I |
(240) |
1,116,373 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-10-08 |
4 |
AS |
$25.02 |
$7,555 |
I/I |
(302) |
1,221,303 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-01-06 |
4 |
AS |
$15.00 |
$6,165 |
I/I |
(411) |
1,129,740 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2022-12-16 |
4 |
AS |
$15.01 |
$8,030 |
I/I |
(535) |
1,138,151 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-03-21 |
4 |
S |
$12.89 |
$8,752 |
D/D |
(679) |
10,043 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-03-22 |
4 |
S |
$12.64 |
$8,962 |
D/D |
(709) |
9,334 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-03-09 |
4 |
AS |
$15.01 |
$10,762 |
I/I |
(717) |
1,088,536 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-01-09 |
4 |
AS |
$15.15 |
$11,044 |
I/I |
(729) |
1,129,422 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-03-23 |
4 |
S |
$12.15 |
$8,955 |
D/D |
(737) |
8,597 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-03-20 |
4 |
S |
$12.61 |
$9,344 |
D/D |
(741) |
10,722 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-03-16 |
4 |
AS |
$13.43 |
$10,623 |
D/D |
(791) |
12,258 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-03-17 |
4 |
S |
$13.28 |
$10,558 |
D/D |
(795) |
11,463 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-08-09 |
4 |
AS |
$25.00 |
$20,688 |
I/I |
(827) |
1,229,458 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-01-10 |
4 |
AS |
$15.17 |
$13,729 |
I/I |
(905) |
1,128,517 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-08-05 |
4 |
AS |
$25.00 |
$34,250 |
I/I |
(1,370) |
1,231,901 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-08-06 |
4 |
AS |
$25.00 |
$40,400 |
I/I |
(1,616) |
1,230,285 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEO |
• • • |
2020-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
1,750 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-08-11 |
4 |
AS |
$25.07 |
$48,061 |
I/I |
(1,917) |
1,227,438 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-04-21 |
4 |
AS |
$15.03 |
$34,734 |
I/I |
(2,311) |
1,070,225 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-06-08 |
4 |
AS |
$20.01 |
$62,031 |
I/I |
(3,100) |
1,040,006 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-01-11 |
4 |
AS |
$15.11 |
$58,989 |
I/I |
(3,904) |
1,124,613 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-04-28 |
4 |
AS |
$15.13 |
$64,726 |
I/I |
(4,278) |
1,065,947 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
President/CEO and Board Chair |
• • – |
2023-03-08 |
4 |
AS |
$15.02 |
$72,892 |
I/I |
(4,853) |
1,089,253 |
0 |
- |
|
61 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
